Robot model
Remebot
Remebot is China's first domestically developed neurosurgical robot, manufactured by Beijing Baihui Weikang Technology.
- Manufacturer
- Remebot
- Form factor
- surgical
- Lifecycle
- active
- Website
- remebot.com.cn ↗
Verified profile
1
Sources on record
0
Tracked changes
Updated recently
Last verified change
Overview
Remebot is China's first domestically developed neurosurgical robot, manufactured by Beijing Baihui Weikang Technology. It received NMPA approval in 2018 and is used for stereotactic neurosurgery including biopsy, hematoma drainage, and deep-brain stimulation electrode placement. The system uses AI-assisted path planning and a robotic arm to achieve sub-millimeter targeting precision for minimally invasive brain procedures.
Verified vs. claimed
- Verified deployments
- None on file
- Sources on file
- 1 source, view all
Safety record
No incidents on record for Remebot.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Sources (1)
- Remebot Neurosurgical Robot | Beijing Baihui Weikang Technology · https://www.remebot.com.cn/
Common questions
- What is Remebot?
- Remebot is China's first domestically developed neurosurgical robot, manufactured by Beijing Baihui Weikang Technology. It received NMPA approval in 2018 and is used for stereotactic neurosurgery including biopsy, hematoma drainage, and deep-brain stimulation electrode placement. The system uses AI-assisted path planning and a robotic arm to achieve sub-millimeter targeting precision for minimally invasive brain procedures.
- Who makes Remebot?
- Remebot is made by Remebot, based in China, founded in 2010.
- Where is Remebot deployed?
- No verified deployments of Remebot are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.
- Is Remebot safe?
- Remebot has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 1 source (no primary) · last reviewed 2026-06-28
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-06-28
Maturity + lifecycle
Lifecycle: active
Architectural position
Cohort: surgical
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Remebot.Machine-readable surfaces
- Markdown mirror: /models/remebot-neurosurgical.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/1168016f-87f8-408d-9843-cbb596193a5f
- Revision history: /models/remebot-neurosurgical/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
DEPLOY Intelligence Score
0.0/ 100
6-month trend
Analysis
Thin deployment record; scale validation still in progress.
Signal flags
Dimension breakdown
Safety Record
Adoption Spread
IP Activity
Deployment Scale
Market Presence
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
Last computed: Jul 3, 2026
Intelligence layer